Aromatase: Biologic Relevance of Tissue-Specific Expression

Aromatase P450 (P450arom) catalyzes the formation of estrogen in several human tissues under the control of alternatively used promoters. Each promoter is regulated by a distinct signaling pathway in a tissue- and hormone-specific manner. This article reviews these regulatory mechanisms in the ovary, adipose tissue, placenta, bone, brain, and various malignant cells. Moreover, the physiological and pathologic impacts of local estrogen biosynthesis in contrast to circulating estrogen or estrogen-responsive human tissues are discussed.

KEYWORDS

Aromatase P450 - P450arom - ovary - adipose tissue - placenta - bone - local estrogen biosynthesis

REFERENCES

• 1 Nelson D R, Koymans L, Kamataki T et al.. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature.  Pharmacogenetics. 1996;  6 1-42
• 2 Means G D, Mahendroo M, Corbin C J et al.. Structural analysis of the gene encoding human aromatase cytochrome P-450, the enzyme responsible for estrogen biosynthesis.  J Biol Chem. 1989;  264 19385-19391
• 3 Harada N, Yamada K, Saito K, Kibe N, Dohmae S, Takagi Y. Structural characterization of the human estrogen synthetase (aromatase) gene.  Biochem Biophys Res Commun. 1990;  166 365-372
• 4 Toda K, Terashima M, Kamamoto T et al.. Structural and functional characterization of human aromatase P450 gene.  Eur J Biochem. 1990;  193 559-565
• 5 Means G D, Kilgore M W, Mahendroo M S, Mendelson C R, Simpson E R. Tissue-specific promoters regulate aromatase cytochrome P450 gene expression in human ovary and fetal tissues.  Mol Endocrinol. 1991;  5 2005-2013
• 6 Mahendroo M S, Means G D, Mendelson C R, Simpson E R. Tissue-specific expression of human P450_arom: the promoter responsible for expression in adipose is different from that utilized in placenta.  J Biol Chem. 1991;  266 11276-11281
• 6a Sebastian S, Bulun S E. A highly complex organization of the regulatory region of the human CYP19 (aromatase) gene revealed by the Human Genome Project.  J Clin Endocrinol Metab. 2001;  86 4600-4602
• 7 Jenkins C, Michael D, Mahendroo M, Simpson E. Exon-specific northern analysis and rapid amplification of cDNA ends (RACE) reveal that the proximal promoter II (PII) is responsible for aromatase cytochrome P450 (CYP19) expression in human ovary.  Mol Cell Endocrinol. 1993;  97 R1-R6
• 8 Mahendroo M S, Mendelson C R, Simpson E R. Tissue-specific and hormonally-controlled alternative promoters regulate aromatase cytochrome P450 gene expression in human adipose tissue.  J Biol Chem. 1993;  268 19463-19470
• 9 Honda S, Harada N, Takagi N. Novel exon I of the aromatase gene specific for aromatase transcripts in human brain.  Biochem Biophys Res Commun. 1994;  198 1153-1160
• 10 Shozu M, Zhao Y, Bulun S E, Simpson E R. Multiple splicing events involved in regulation of human aromatase expression by a novel promoter, I.6  Endocrinology. 1998;  139 1610-1617
• 11 Simpson E R, Zhao Y, Agarwal V R et al.. Aromatase expression in health and disease.  Recent Prog Horm Res. 1997;  52 185-214
• 12 Callard G V, Petro Z, Ryan K J. Phylogenetic distribution of aromatase and other androgen-converting enzymes in the central nervous system.  Endocrinology. 1978;  103 2283-2290
• 13 Callard G V, Petro Z, Ryan K J. Aromatization and 5α-reduction in brain and non-neural tissues of a cyclostome (Petromyzan marinua).  Gen Comp Endocrinol. 1980;  42 155-159
• 14 Callard G V. Aromatization is cyclic AMP-dependent in cultured reptilian brain cells.  Brain Res. 1981;  204 451-454
• 15 Hutchinson J B. Hormonal control of behaviour: steroid action in the brain.  Curr Opin Neurobiol. 1991;  1 562-570
• 16 Michael M D, Kilgore M W, Morohashi K, Simpson E R. Ad4BP/SF-1 regulates cyclic AMP-induced transcription from the proximal promoter (PII) of the human aromatase P450 (CYP19) gene in the ovary.  J Biol Chem. 1995;  270 13561-13566
• 17 Fitzpatrick S L, Richards J S. Identification of a cyclic adenosine 3′,5′-monophosphate-response element in the rat aromatase promoter that is required for transcriptional activation in rat granulose cells and R2C leydig cells.  Mol Endocrinol. 1994;  8 1309-1319
• 18 Luo X, Ikeda Y, Parker K L. A cell-specific nuclear receptor is essential for adrenal and gonadal development.  Cell. 1994;  77 481-490
• 19 Lala D S, Rice D A, Parker K L. Steroidogenic factor 1, a key regulation of steroidogenic gene expression, is the mouse homolog of fushi tarazu-factor 1.  Mol Endocrinol. 1992;  6 1249-1258
• 20 Michael M D, Michael L F, Simpson E R. A CRE-like sequence that binds CREB and contributes to cAMP-dependent regulation of the proximal promoter of the human aromatase P450 (CYP19) gene.  Mol Cell Endocrinol. 1997;  134 147-156
• 21 Hinshelwood M M, Michael M D, Simpson E R. The 5′-flanking region of the ovarian promoter of the bovine CYP19 gene contains a deletion in a cyclicadenosine 3′,5′-monophosphate-like responsive sequence.  Endocrinology. 1997;  138 3704-3710
• 22 Zhao Y, Mendelson C R, Simpson E R. Characterization of the sequences of the human CYP19 (aromatase) gene that mediate regulation by glucocorticoids in adipose stromal cells and fetal hepatocytes.  Mol Endocrinol. 1995;  9 340-349
• 23 Zhao Y, Nichols J E, Bulun S E, Mendelson C R, Simpson E R. Aromatase P450 gene expression in human adipose tissue: role of a Jak/STAT pathway in regulation of the adipose-specific promoter.  J Biol Chem. 1995;  270 16449-16457
• 24 Reichardt H M, Schutz G. Glucocorticoid signalling: multiple variations of a common theme.  Mol Cell Endocrinol. 1998;  146 1-6
• 25 Price T, O'Brien S, Dunaif A, Simpson E R. Comparison of aromatase cytochrome P450 mRNA levels in adipose tissue from the abdomen and buttock using competitive polymerase chain reaction amplification.  Proc Soc Gynecol Invest. 1992;  1 179
• 26 Berkovitz G D, Bisat T, Carter K M. Aromatase activity in microsomal preparations of human genital skin fibroblasts: influence of glucocorticoids.  J Steroid Biochem. 1989;  33 341-347
• 27 Bruch H R, Wolf L, Budde R, Romalo G, Schweikert H U. Androstenedione metabolism in cultured human osteoblast-like cells.  J Clin Endocrinol Metab. 1992;  75 101-105
• 28 Nawata H, Tanaka S, Tanaka S et al.. Aromatase in bone cell: association with osteoporosis in postmenopausal women.  J Steroid Biochem Mol Biol. 1995;  53 165-174
• 29 Harada N, Utsume T, Takagi Y. Tissue-specific expression of the human aromatase cytochrome P-450 gene by alternative use of multiple exons 1 and promoters, and switching of tissue-specific exons 1 in carcinogenesis.  Proc Natl Acad Sci USA. 1993;  90 11312-11316
• 30 Agarwal V R, Bulun S E, Leitch M, Rohrich R, Simpson E R. Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients.  J Clin Endocrinol Metab. 1996;  81 3843-3849
• 31 Zhao Y, Agarwal V R, Mendelson C R, Simpson E R. Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE₂ via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene.  Endocrinology. 1996;  137 5739-5742
• 32 Agarwal V R, Ashanullah C I, Simpson E R, Bulun S E. Alternatively spliced transcripts of the aromatase cytochrome P450 (CYP19) gene in adipose tissue of women.  J Clin Endocrinol Metab. 1997;  82 70-74
• 33 Bulun S E, Simpson E R. Competitive RT-PCR analysis indicates levels of aromatase cytochrome P450 transcripts in adipose tissue of buttocks, thighs, and abdomen of women increase with advancing age.  J Clin Endocrinol Metab. 1994;  78 428-432
• 34 Wei J, Xu H, Davies J L, Hemmings J P. Increase of plasma IL-6 concentration with age in healthy subjects.  Life Sci. 1992;  51 1953-1956
• 35 Daynes R A, Araneo B A, Ershler W B, Maloney C, Li G Z, Ryu S Y. Altered regulation of IL-6 production with normal aging.  J Immunol. 1993;  150 5219-5230
• 36 Petruschke T, Hauner H. Tumor necrosis factor-alpha prevents the differentiation of human adipocyte precursor cells and caused delipidation of developed fat cells.  J Clin Endocrinol Metab. 1993;  76 742-747
• 37 Kawashima I, Ohsumi J, Mita-Honjo K et al.. Molecular cloning of cDNA encoding adipogenesis inhibitory factor and identity with interleukin-11.  FEBS Lett. 1991;  283 199-202
• 38 Kliewer S A, Lenhard J M, Willson T M, Patel I, Morris D C, Lehmann J M. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation.  Cell. 1995;  83 813-819
• 39 Rubin G L, Zhao Y, Kalus A M, Simpson E R. Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy.  Cancer Res. 2000;  60 1604-1608
• 40 Rink J D, Simpson E R, Barnard J J, Bulun S E. Cellular chacterization of adipose tissue from various body sites of women.  J Clin Endocrinol Metab. 1996;  81 2443-2447
• 41 Bulun S E, Sharda G, Rink J, Sharma S, Simpson E R. Distribution of aromatase P450 transcripts and adipose fibroblasts in the human breast.  J Clin Endocrinol Metab. 1996;  81 1273-1277
• 42 Harada N. Aberrant expression of aromatase in breast cancer tissues.  J Steroid Biochem Mol Biol. 1997;  61 175-184
• 43 Zhou D, Zhou C, Chen S. Gene regulation studies of aromatase expression in breast cancer and adipose stromal cells.  J Steroid Biochem Mol Biol. 1997;  61 273-280
• 44 Zhou J, Gurates B, Yang S, Sebastian S, Bulun S E. Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta.  Cancer Res. 2001;  61 2328-2334
• 45 Meng L, Zhou J, Sasano H, Suzuki T, Zeitoun K M, Bulun S E. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.  Cancer Res. 2001;  61 2250-2255
• 46 Toda K, Miyahara K, Kawamoto T, Ikeda H, Sagara Y, Shizuta Y. Characterization of a cis-acting regulatory element involved in human aromatase P450 gene expression.  Eur J Biochem. 1992;  205 303-309
• 47 Yamada K, Harada N, Honda S, Takagi Y. Regulation of placenta-specific expression of the aromatase cytochrome P450 gene: involvement of the trophoblast-specific element binding protein.  J Biol Chem. 1995;  270 25064-25069
• 48 Sun T, Zhao Y, Fisher C R, Kilgore M, Mendelson C R, Simpson E R. Characterization of cis-acting elements of the human aromatase P450 (CYP19) gene that mediate regulation by retinoids in human choriocarcinoma cells (abstract OR38-8). In: Program & Abstracts of the 10th International Congress of Endocrinology Vol. 1 June 11-14, 1996 San Francisco, CA; Washington, DC; Endocrine Society
• 49 Stephanon A, Sarlis N J, Richards R, Handwerger S. Expression of retinoic acid receptor subtypes and cellualr retinoic acid binding protein II in MRNAs during differentiation of human trophoblast cells.  Biochem Biophys Res Commun. 1994;  202 772-780
• 50 Barak Y, Nelson M C, Ong E S et al.. PPAR gamma is required for placental, cardiac, and adipose tissue development.  Mol Cell. 1999;  4 585-595
• 51 Jiang B, Kamat A, Mendelson C R. Hypoxia prevents induction of aromatase expression in human trophoblasts: potential inhibitory role of the hypoxia-inducible transcription factor Mash-2 (mammalian achaete-scute homologous protein-2).  Mol Endocrinol. 2000;  14 1661-1673
• 52 Kamat A, Graves K H, Smith M E, Richardson J A, Mendelson C R. A 500-bp region, approximately 40 kb upstream of the human CYP19 (aromatase) gene, mediates placenta-specific expression in transgenic mice.  Proc Natl Acad Sci USA. 1999;  96 4575-4580
• 53 Smith E P, Boyd J, Frank G R et al.. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man.  N Engl J Med. 1994;  331 1056-1061
• 54 Carani C, Qin K, Simoni M et al.. Aromatase deficiency in the male: effect of testosterone and estradiol treatment.  N Engl J Med. 1997;  337 91-95
• 55 Mullis P E, Yoshimura N, Kuhlmann B, Lippuner K, Jaeger P, Harada H. Aromatase deficiency in a female who is compound heterozygote for two new point mutations in the P450_arom gene: impact of estrogens on hypergonadotropic hypogonadism, multicystic ovaries, and bone densitometry in childhood.  J Clin Endocrinol Metab. 1997;  82 1739-1745
• 56 Sasano H, Uzuki M, Sawai T et al.. Aromatase in bone tissue.  J Bone Miner Res. 1997;  12 1416-1423
• 57 Shozu M, Simpson E R. Aromatase expression of human osteoblast-like cells.  Mol Cell Endocrinol. 1998;  139 117-129
• 58 Sasano H, Frost A R, Saitoh R et al.. Aromatase and 17β-hydroxysteroid dehydrogenase type 1 in human breast carcinoma.  J Clin Endocrinol Metab. 1996;  81 4042-4046
• 59 Lea C K, Ebrahim H, Tennant S, Flanagan A M. Aromatase cytochrome P450 transcripts are detected in fractured human bone but not in normal skeletal tissue.  Bone. 1997;  21 433-440
• 60 Lauber M E, Lichtensteiger W. Pre- and postnatal ontogeny of aromatase cytochrome P450 messenger RNA expression in the male rat brain studied by in situ hybridization.  Endocrinology. 1994;  135 1661-1668
• 61 Wagner C K, Morrell J I. Neuroanatomical distribution of aromatase in RNA in the rat brain: indications of regional regulation.  J Steroid Biochem Mol Biol. 1997;  61 307-314
• 62 Sasano H, Takashashi K, Satoh F, Nagura H, Harada N. Aromatase in the central nervous system.  Clin Endocrinol (Oxf). 1998;  48 325-329
• 63 Abdelgadir S E, Resko J A, Ojeda S R, Lephart E D, McPhaul M J, Roselli C E. Androgens regulate aromatase cytochrome P450 messenger ribonucleic acid in the rat brain.  Endocrinology. 1994;  135 395-401
• 64 Abe-Dohmae S, Takagi Y, Harada N. Autonomous expression of aromatase during development of mouse brain is modulated by neurotransmitters.  J Steroid Biochem Mol Biol. 1997;  61 299-306
• 65 Lanoux M J, Cleland W H, Mendelson C R, Carr B R, Simpson E R. Factors affecting the conversion of androstenedione to estrogens by human fetal hepatocytes in monolayer culture.  Endocrinology. 1985;  117 361-367
• 66 Harada N. A unique aromatase (P450arom) mRNA formed by alternative use of tissue specific exons I in human skin fibroblasts.  Biochem Biophys Res Commun. 1992;  189 1001-1007
• 67 Toda K, Simpson E R, Mendelson C R, Shizuta Y, Kilgore M W. Expression of the gene encoding aromatase cytochrome P450 (CYP19) in fetal tissues.  Mol Endocrinol. 1994;  8 210-217
• 68 Zeitoun K, Takayama K, Michael M D, Bulun S E. Stimulation of aromatase promoter (II) activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of steroidogenic factor-1 and chicken ovalbumin upstream promoter transcription factor to the same cis-acting element.  Mol Endocrinol. 1999;  13 239-253
• 69 Harada N, Sasano H, Murakami H, Ohkuma T, Nagura H, Takagi Y. Localized expression of aromatase in human vascular tissues.  Circ Res. 1999;  84 1285-1291
• 70 Sasano H, MuraKami H, Shizawa S, Satomi S, Nagura H, Harada N. Aromatase and sex steroid receptors in human vena cava.  Endocr J. 1999;  46 233-242
• 71 Agarwal V R, Takayama K, Van Wyk J J, Sasano H, Simpson E R, Bulun S E. Molecular basis of severe gynecomatsia associated with aromatase expression in a fibrolamellar hepatocellular carcinoma.  J Clin Endocrinol Metab. 1998;  83 1797-1800
• 72 Bulun S E, Rosenthal I M, Brodie A M et al.. Use of tissue-specific promoters in the regulation of aromatase cytochrome P450 gene expression in human testicular and ovarian sex cord tumors as well as in normal fetal and adult gonads.  J Clin Endocrinol Metab. 1994;  78 1616-1621
• 73 Young J, Bulun S E, Agarwal V, Couzinet B, Mendelson C R. Aromatase expression in a feminizing adrenocortical tumor.  J Clin Endocrinol Metab. 1996;  81 3173-3176
• 74 Bulun S E, Economos K, Miller D, Simpson E R. CYP19 (aromatase) gene expression in human malignant endometrial tumors.  J Clin Endocrinol Metab. 1994;  79 1831-1834
• 75 Noble L S, Simpson E R, Johns A, Bulun S E. Aromatase expression in endometriosis.  J Clin Endocrinol Metab. 1996;  81 174-179
• 76 Naftolin F, Ryan K J, Davies I J et al.. The formation of estrogens by central neuroendocrine tissues.  Recent Prog Horm Res. 1975;  31 295-319
• 77 Siiteri P K, MacDonald P C. Role of extraglandular estrogen in human endocrinology. In: Green RO, Astwood EB Handbook of Physiology. Vol. 2 American Physiological Society 1973: 619-629
• 78 Melton L J. Epidemiology of spinal osteoporosis.  Spine. 1997;  22 2S-11S
• 79 Huang Z, Hankinson S E, Colditz G A et al.. Dual effects of weight and weight gain on breast cancer risk.  JAMA. 1997;  278 1407-1411
• 80 Hemsell D L, Edman C D, Marks J F, Siiteri P K, MacDonald P C. Plasma precursors of estrogen, II: Correlation of the extent of conversion of plasma androstenedione to estrone with age.  J Clin Endocrinol Metab. 1974;  38 476-479
• 81 Tsai-Morris C H, Aquilana D R, Dufau M L. Cellular localisation of rat testicular aromatase activity during development.  Endocrinology. 1985;  116 38-46
• 82 Nitta H, Bunick D, Hess R A et al.. Germ cells of the mouse testis express P450 aromatase.  Endocrinology. 1993;  132 1396-1401
• 83 Morishima A, Grumbach M M, Simpson E R, Fisher C, Qin M. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of oestrogens.  J Clin Endocrinol Metab. 1995;  80 3689-3698
• 84 Toda K, Okada T, Akira S et al.. Oestrogen at the neonatal stage is critical for reproductive ability of male mice as revealed by supplementation with 17β-oestradiol to aromatase gene (Cyp19) knockout mice.  J Endocrinol. 2001;  168 455-463
• 85 Robertson K M, Simpson E R, Lacham-Kaplan O, Jones M EE. Characterization of the fertility of the male aromatase knockout (ArKO) mouse.  J Androl. 2001;  22 825-830
• 86 Labrie F, Belanger A, Luu-The V et al.. DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during aging.  Steroids. 1998;  63 322-328
• 87 Corbould A M, Judd S J, Rodgers R J. Expression of types 1,2 and 3 β-hydroxysteroid dehydrogenase in subcutaneous abdominal and intra-abdominal adipose tissue of women.  J Clin Endocrinol Metab. 1998;  83 187-194
• 88 Pasqualini J R, Chetrite G, Blacker C et al.. Concentrations of estrone, estradiol and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients.  J Clin Endocrinol Metab. 1996;  81 1460-1464